Ascendiant Capital Markets Forecasts Synergy CHC Q2 Earnings

Synergy CHC Corp. (NASDAQ:SNYRFree Report) – Analysts at Ascendiant Capital Markets cut their Q2 2026 earnings estimates for Synergy CHC in a research report issued to clients and investors on Tuesday, June 9th. Ascendiant Capital Markets analyst E. Woo now expects that the company will earn ($0.01) per share for the quarter, down from their previous estimate of $0.04. Ascendiant Capital Markets has a “Buy” rating and a $5.50 price objective on the stock. The consensus estimate for Synergy CHC’s current full-year earnings is ($0.19) per share. Ascendiant Capital Markets also issued estimates for Synergy CHC’s FY2026 earnings at ($0.19) EPS.

Separately, Weiss Ratings downgraded Synergy CHC from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Thursday. Two investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $6.25.

View Our Latest Stock Report on Synergy CHC

Synergy CHC Price Performance

SNYR opened at $0.20 on Monday. Synergy CHC has a fifty-two week low of $0.19 and a fifty-two week high of $4.00. The firm has a market capitalization of $2.96 million, a PE ratio of -0.14 and a beta of -0.27. The company’s 50-day moving average is $0.38 and its 200 day moving average is $1.21.

Synergy CHC (NASDAQ:SNYRGet Free Report) last released its quarterly earnings data on Thursday, May 14th. The company reported ($0.23) earnings per share for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.26). The business had revenue of $5.49 million during the quarter. Synergy CHC had a negative net margin of 60.02% and a negative return on equity of 19.51%.

Institutional Investors Weigh In On Synergy CHC

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Heartland Advisors Inc. bought a new position in Synergy CHC during the 3rd quarter valued at $1,342,000. XTX Topco Ltd bought a new stake in shares of Synergy CHC in the 2nd quarter worth $57,000. DRW Securities LLC bought a new stake in shares of Synergy CHC in the 4th quarter worth $36,000. Virtu Financial LLC purchased a new stake in shares of Synergy CHC in the third quarter valued at about $38,000. Finally, Geode Capital Management LLC purchased a new stake in shares of Synergy CHC in the second quarter valued at about $29,000.

Synergy CHC Company Profile

(Get Free Report)

Synergy CHC Corp. engages in the marketing and distribution of branded health and wellness products. The company was founded on December 29, 2010 and is headquartered in Westbrook, ME.

See Also

Earnings History and Estimates for Synergy CHC (NASDAQ:SNYR)

Receive News & Ratings for Synergy CHC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synergy CHC and related companies with MarketBeat.com's FREE daily email newsletter.